Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Free Cash Flow: 2009-2025

Historic Free Cash Flow for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Sep 2025 value amounting to $163,392.

  • Cumberland Pharmaceuticals' Free Cash Flow fell 64.49% to $163,392 in Q3 2025 from the same period last year, while for Sep 2025 it was $6.7 million, marking a year-over-year increase of 523.64%. This contributed to the annual value of -$678,647 for FY2024, which is 111.68% down from last year.
  • According to the latest figures from Q3 2025, Cumberland Pharmaceuticals' Free Cash Flow is $163,392, which was down 80.01% from $817,315 recorded in Q2 2025.
  • Cumberland Pharmaceuticals' 5-year Free Cash Flow high stood at $5.2 million for Q2 2023, and its period low was -$2.2 million during Q1 2024.
  • For the 3-year period, Cumberland Pharmaceuticals' Free Cash Flow averaged around $905,955, with its median value being $817,315 (2025).
  • Per our database at Business Quant, Cumberland Pharmaceuticals' Free Cash Flow surged by 1,670.68% in 2022 and then slumped by 759.50% in 2023.
  • Over the past 5 years, Cumberland Pharmaceuticals' Free Cash Flow (Quarterly) stood at $2.0 million in 2021, then surged by 94.38% to $3.8 million in 2022, then crashed by 73.85% to $991,448 in 2023, then spiked by 91.87% to $1.9 million in 2024, then plummeted by 64.49% to $163,392 in 2025.
  • Its last three reported values are $163,392 in Q3 2025, $817,315 for Q2 2025, and $3.9 million during Q1 2025.